精选80The Crypto Basic（RSS）股市多源精选 ×13
Moderna股价翻倍，癌症疫苗III期试验成功
Moderna Stock Doubles, Adding $26.4 Billion After Cancer Vaccine Meets Both Phase 3 Goals
推荐理由
重大临床成功引发个股翻倍行情，涉及具体涨幅与市值变动，值得关注医药板块及Moderna后续走势。
Moderna stock more than doubled at its premarket peak Wednesday after the company’s personalized mRNA cancer treatment, developed with Merck, succeeded in a pivotal Phase 3 melanoma trial. MRNA rose by approximately 105% from Tuesday’s $62.96 closing price, reaching an estimated peak near $129.07.
Visit Website
更进一步：量化金融体系
看懂新闻只是起点——沿量化金融路径，把它变成能交付的工程能力